Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedJun 30, 2026
DataAggregated Company Financials
Companies5
  • 7D0.2%
  • 3M-5.8%
  • 1Y-34.9%
  • YTDn/a

The Drug Retail industry has been flat over the last week, but MARX Biotech has lost 4.1%. Unfortunately though, the industry is down 35% over the past 12 months. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 Jul 2026NT$19.9bNT$34.3bNT$765.8m22.5x26x0.6x
Fri, 29 May 2026NT$19.0bNT$34.3bNT$765.8m21.8x24.8x0.6x
Sun, 26 Apr 2026NT$21.2bNT$34.3bNT$687.6m19.6x30.8x0.6x
Tue, 24 Mar 2026NT$20.8bNT$34.2bNT$695.1m20.1x29.9x0.6x
Thu, 19 Feb 2026NT$23.0bNT$33.9bNT$712.6m21.6x32.2x0.7x
Sat, 17 Jan 2026NT$22.3bNT$33.9bNT$712.6m21.6x31.3x0.7x
Mon, 15 Dec 2025NT$21.7bNT$33.9bNT$712.6m19.9x30.4x0.6x
Wed, 12 Nov 2025NT$24.9bNT$33.8bNT$702.0m24.6x35.4x0.7x
Fri, 10 Oct 2025NT$27.1bNT$33.5bNT$755.9m27.1x35.9x0.8x
Sun, 07 Sep 2025NT$30.5bNT$33.5bNT$755.9m31.2x40.4x0.9x
Tue, 05 Aug 2025NT$31.7bNT$32.8bNT$754.7m27.7x42x1x
Thu, 03 Jul 2025NT$30.2bNT$32.8bNT$754.7m28x40x0.9x
Sat, 31 May 2025NT$32.4bNT$32.8bNT$754.7m30.2x43x1x
Mon, 28 Apr 2025NT$32.8bNT$32.3bNT$718.2m37.6x45.6x1x
Wed, 26 Mar 2025NT$36.4bNT$32.1bNT$701.3m44.8x51.9x1.1x
Fri, 21 Feb 2025NT$34.5bNT$31.8bNT$755.8m41.1x45.7x1.1x
Sun, 19 Jan 2025NT$32.5bNT$31.8bNT$755.8m43x43x1x
Tue, 17 Dec 2024NT$33.2bNT$31.8bNT$755.8m45.7x43.9x1x
Thu, 14 Nov 2024NT$38.1bNT$31.7bNT$777.8m112.5x48.9x1.2x
Sat, 12 Oct 2024NT$40.6bNT$31.0bNT$840.8m113.3x48.3x1.3x
Mon, 09 Sep 2024NT$38.6bNT$31.0bNT$840.8m111.7x45.9x1.2x
Wed, 07 Aug 2024NT$39.4bNT$30.7bNT$873.1m74.2x45.1x1.3x
Fri, 05 Jul 2024NT$43.4bNT$30.7bNT$873.1m78.3x49.7x1.4x
Sun, 02 Jun 2024NT$48.5bNT$30.7bNT$873.1m82.5x55.5x1.6x
Tue, 30 Apr 2024NT$49.6bNT$30.3bNT$935.7m58.9x53x1.6x
Thu, 28 Mar 2024NT$52.5bNT$30.2bNT$941.1m56.7x55.7x1.7x
Sat, 24 Feb 2024NT$53.1bNT$29.9bNT$964.0m59.9x55.1x1.8x
Mon, 22 Jan 2024NT$53.0bNT$30.0bNT$1.0b49.3x50.7x1.8x
Wed, 20 Dec 2023NT$52.5bNT$26.8bNT$949.0m57.4x55.3x2x
Fri, 17 Nov 2023NT$52.1bNT$26.6bNT$974.7m46.4x53.5x2x
Sun, 15 Oct 2023NT$55.4bNT$26.3bNT$1.0b46.2x54.3x2.1x
Tue, 12 Sep 2023NT$53.4bNT$26.3bNT$1.0b45.8x52.3x2x
Thu, 10 Aug 2023NT$54.7bNT$26.7bNT$1.3b25x43.3x2x
Sat, 08 Jul 2023NT$53.2bNT$26.8bNT$1.3b28.5x42.2x2x
Price to Earnings Ratio

42.2x


Total Market Cap: NT$53.2bTotal Earnings: NT$1.3bTotal Revenue: NT$26.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 44.4x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 26.0x which is lower than its 3-year average PE of 44.4x.
  • The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 0.58x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 15% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market-5.96%
Consumer Staples0.98%
Food and Staples Retail0.93%
Drug Retail0.25%
Food Retail1.08%
Big Box Super Stores0%0
Food Distributors-1.63%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6469 Great Tree PharmacyNT$74.901.1%
+NT$120.0m
-42.2%PE19.8x
6929 We Can MedicinesNT$23.750.2%
+NT$2.3m
-28.7%PS0.3x

Latest News